The Participation of Secondary Clinical Episodes in the Epidemiology of Vivax Malaria during Pre- and Post-Implementation of Focal Control in the State of Oaxaca, Mexico

The participation of vivax malaria secondary clinical was researched in a retrospective cohort of 33,414 confirmed cases occurring between 1994 and 2005 in the state of Oaxaca, Mexico. Secondary episodes occurred in 23.4% of all primary cases. An increase in secondary episodes was associated with pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of tropical medicine and hygiene 2009-06, Vol.80 (6), p.889-895
Hauptverfasser: Rodriguez, Mario H, Betanzos-Reyes, Angel F, Hernandez-Avila, Juan E, Mendez-Galvan, Jorge F, Danis-Lozano, Rogelio, Altamirano-Jimenez, Armando
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 895
container_issue 6
container_start_page 889
container_title The American journal of tropical medicine and hygiene
container_volume 80
creator Rodriguez, Mario H
Betanzos-Reyes, Angel F
Hernandez-Avila, Juan E
Mendez-Galvan, Jorge F
Danis-Lozano, Rogelio
Altamirano-Jimenez, Armando
description The participation of vivax malaria secondary clinical was researched in a retrospective cohort of 33,414 confirmed cases occurring between 1994 and 2005 in the state of Oaxaca, Mexico. Secondary episodes occurred in 23.4% of all primary cases. An increase in secondary episodes was associated with primary cases occurring during the dry seasons (risk ratio [RR] = 1.68, 95% CI: 1.45-1.96). The incidence of secondary episodes peaked at an older age, occurred similarly in men and women mostly during low mosquito abundance, and had a uniform distribution among localities. A reduction in secondary episodes was associated with the administration of an increased dose and early administration of primaquine (RR = 0.32, 95% CI: 0.26-0.38). However, limitations to distinguish relapses from re-infections impede assessment of the new treatment effect on relapses and its contribution to malaria control in the area. These findings highlight the need for new therapeutic schemes to radical cure of P. vivax infections and operational research aimed at parasite pool elimination.
doi_str_mv 10.4269/ajtmh.2009.80.889
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67283766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20802804</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-d0a746e035695cc4db863cf742ef283684baa4c24b5d7a3d4f5aa1ee7ff8546b3</originalsourceid><addsrcrecordid>eNqFkcFu1DAURSMEotPCB7BB3sCKDLbjOM4SjVqo1KojtbC1XhxnxpVjBzvTmX4Sf1lnGsqSlWW9c8-T3s2yDwQvGeX1V7gf--2SYlwvBV4KUb_KFoRVPCecla-zBcaY5jUvqpPsNMZ7jImghLzNTkjNKkEZW2R_7rYarSGMRpkBRuMd8h261cq7FsIjWlnjjAKLzgcTfasjMg6NKZP-re6Nt37zOEV-mQc4oGuwEAygdheM26B10DkC16K1j2N-2Q9W99qNL3su_KReeTcGb_-ab9NcT9MbOICCL-haH4zy77I3Hdio38_vWfbz4vxu9SO_uvl-ufp2lStWFGPeYqgY17goeV0qxdpG8EJ1FaO6o6LggjUATFHWlG0FRcu6EoBoXXWdKBlvirPs87N3CP73TsdR9iYqbS047XdR8ippKs7_C1IsMBWYJZA8gyr4GIPu5BBMn64rCZZTkfJYpJyKlALLVGTKfJzlu6bX7b_E3FwCPs0AxHTELoBTJr5wlJS8Ko-imduazXZvgpaxB2uTlsj9fp_W8ePCJ9t9trM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20802804</pqid></control><display><type>article</type><title>The Participation of Secondary Clinical Episodes in the Epidemiology of Vivax Malaria during Pre- and Post-Implementation of Focal Control in the State of Oaxaca, Mexico</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Rodriguez, Mario H ; Betanzos-Reyes, Angel F ; Hernandez-Avila, Juan E ; Mendez-Galvan, Jorge F ; Danis-Lozano, Rogelio ; Altamirano-Jimenez, Armando</creator><creatorcontrib>Rodriguez, Mario H ; Betanzos-Reyes, Angel F ; Hernandez-Avila, Juan E ; Mendez-Galvan, Jorge F ; Danis-Lozano, Rogelio ; Altamirano-Jimenez, Armando</creatorcontrib><description>The participation of vivax malaria secondary clinical was researched in a retrospective cohort of 33,414 confirmed cases occurring between 1994 and 2005 in the state of Oaxaca, Mexico. Secondary episodes occurred in 23.4% of all primary cases. An increase in secondary episodes was associated with primary cases occurring during the dry seasons (risk ratio [RR] = 1.68, 95% CI: 1.45-1.96). The incidence of secondary episodes peaked at an older age, occurred similarly in men and women mostly during low mosquito abundance, and had a uniform distribution among localities. A reduction in secondary episodes was associated with the administration of an increased dose and early administration of primaquine (RR = 0.32, 95% CI: 0.26-0.38). However, limitations to distinguish relapses from re-infections impede assessment of the new treatment effect on relapses and its contribution to malaria control in the area. These findings highlight the need for new therapeutic schemes to radical cure of P. vivax infections and operational research aimed at parasite pool elimination.</description><identifier>ISSN: 0002-9637</identifier><identifier>EISSN: 1476-1645</identifier><identifier>DOI: 10.4269/ajtmh.2009.80.889</identifier><identifier>PMID: 19478244</identifier><identifier>CODEN: AJTHAB</identifier><language>eng</language><publisher>Deerfield, IL: ASTMH</publisher><subject>Adolescent ; Adult ; Aged ; Antimalarials - administration &amp; dosage ; Antimalarials - therapeutic use ; Biological and medical sciences ; Child ; Child, Preschool ; Chloroquine - administration &amp; dosage ; Chloroquine - therapeutic use ; Cohort Studies ; Drug Therapy, Combination ; Female ; Human protozoal diseases ; Humans ; Incidence ; Infant ; Infectious diseases ; Malaria ; Malaria, Vivax - epidemiology ; Malaria, Vivax - prevention &amp; control ; Male ; Medical sciences ; Mexico - epidemiology ; Middle Aged ; Mosquito Control - methods ; Parasitic diseases ; Primaquine - administration &amp; dosage ; Primaquine - therapeutic use ; Protozoal diseases ; Retrospective Studies ; Seasons ; Young Adult</subject><ispartof>The American journal of tropical medicine and hygiene, 2009-06, Vol.80 (6), p.889-895</ispartof><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-d0a746e035695cc4db863cf742ef283684baa4c24b5d7a3d4f5aa1ee7ff8546b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21567589$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19478244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodriguez, Mario H</creatorcontrib><creatorcontrib>Betanzos-Reyes, Angel F</creatorcontrib><creatorcontrib>Hernandez-Avila, Juan E</creatorcontrib><creatorcontrib>Mendez-Galvan, Jorge F</creatorcontrib><creatorcontrib>Danis-Lozano, Rogelio</creatorcontrib><creatorcontrib>Altamirano-Jimenez, Armando</creatorcontrib><title>The Participation of Secondary Clinical Episodes in the Epidemiology of Vivax Malaria during Pre- and Post-Implementation of Focal Control in the State of Oaxaca, Mexico</title><title>The American journal of tropical medicine and hygiene</title><addtitle>Am J Trop Med Hyg</addtitle><description>The participation of vivax malaria secondary clinical was researched in a retrospective cohort of 33,414 confirmed cases occurring between 1994 and 2005 in the state of Oaxaca, Mexico. Secondary episodes occurred in 23.4% of all primary cases. An increase in secondary episodes was associated with primary cases occurring during the dry seasons (risk ratio [RR] = 1.68, 95% CI: 1.45-1.96). The incidence of secondary episodes peaked at an older age, occurred similarly in men and women mostly during low mosquito abundance, and had a uniform distribution among localities. A reduction in secondary episodes was associated with the administration of an increased dose and early administration of primaquine (RR = 0.32, 95% CI: 0.26-0.38). However, limitations to distinguish relapses from re-infections impede assessment of the new treatment effect on relapses and its contribution to malaria control in the area. These findings highlight the need for new therapeutic schemes to radical cure of P. vivax infections and operational research aimed at parasite pool elimination.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antimalarials - administration &amp; dosage</subject><subject>Antimalarials - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chloroquine - administration &amp; dosage</subject><subject>Chloroquine - therapeutic use</subject><subject>Cohort Studies</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Human protozoal diseases</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Malaria</subject><subject>Malaria, Vivax - epidemiology</subject><subject>Malaria, Vivax - prevention &amp; control</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mexico - epidemiology</subject><subject>Middle Aged</subject><subject>Mosquito Control - methods</subject><subject>Parasitic diseases</subject><subject>Primaquine - administration &amp; dosage</subject><subject>Primaquine - therapeutic use</subject><subject>Protozoal diseases</subject><subject>Retrospective Studies</subject><subject>Seasons</subject><subject>Young Adult</subject><issn>0002-9637</issn><issn>1476-1645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAURSMEotPCB7BB3sCKDLbjOM4SjVqo1KojtbC1XhxnxpVjBzvTmX4Sf1lnGsqSlWW9c8-T3s2yDwQvGeX1V7gf--2SYlwvBV4KUb_KFoRVPCecla-zBcaY5jUvqpPsNMZ7jImghLzNTkjNKkEZW2R_7rYarSGMRpkBRuMd8h261cq7FsIjWlnjjAKLzgcTfasjMg6NKZP-re6Nt37zOEV-mQc4oGuwEAygdheM26B10DkC16K1j2N-2Q9W99qNL3su_KReeTcGb_-ab9NcT9MbOICCL-haH4zy77I3Hdio38_vWfbz4vxu9SO_uvl-ufp2lStWFGPeYqgY17goeV0qxdpG8EJ1FaO6o6LggjUATFHWlG0FRcu6EoBoXXWdKBlvirPs87N3CP73TsdR9iYqbS047XdR8ippKs7_C1IsMBWYJZA8gyr4GIPu5BBMn64rCZZTkfJYpJyKlALLVGTKfJzlu6bX7b_E3FwCPs0AxHTELoBTJr5wlJS8Ko-imduazXZvgpaxB2uTlsj9fp_W8ePCJ9t9trM</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Rodriguez, Mario H</creator><creator>Betanzos-Reyes, Angel F</creator><creator>Hernandez-Avila, Juan E</creator><creator>Mendez-Galvan, Jorge F</creator><creator>Danis-Lozano, Rogelio</creator><creator>Altamirano-Jimenez, Armando</creator><general>ASTMH</general><general>American Society of Tropical Medecine and Hygiene</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope><scope>F1W</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20090601</creationdate><title>The Participation of Secondary Clinical Episodes in the Epidemiology of Vivax Malaria during Pre- and Post-Implementation of Focal Control in the State of Oaxaca, Mexico</title><author>Rodriguez, Mario H ; Betanzos-Reyes, Angel F ; Hernandez-Avila, Juan E ; Mendez-Galvan, Jorge F ; Danis-Lozano, Rogelio ; Altamirano-Jimenez, Armando</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-d0a746e035695cc4db863cf742ef283684baa4c24b5d7a3d4f5aa1ee7ff8546b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antimalarials - administration &amp; dosage</topic><topic>Antimalarials - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chloroquine - administration &amp; dosage</topic><topic>Chloroquine - therapeutic use</topic><topic>Cohort Studies</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Human protozoal diseases</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Malaria</topic><topic>Malaria, Vivax - epidemiology</topic><topic>Malaria, Vivax - prevention &amp; control</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mexico - epidemiology</topic><topic>Middle Aged</topic><topic>Mosquito Control - methods</topic><topic>Parasitic diseases</topic><topic>Primaquine - administration &amp; dosage</topic><topic>Primaquine - therapeutic use</topic><topic>Protozoal diseases</topic><topic>Retrospective Studies</topic><topic>Seasons</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodriguez, Mario H</creatorcontrib><creatorcontrib>Betanzos-Reyes, Angel F</creatorcontrib><creatorcontrib>Hernandez-Avila, Juan E</creatorcontrib><creatorcontrib>Mendez-Galvan, Jorge F</creatorcontrib><creatorcontrib>Danis-Lozano, Rogelio</creatorcontrib><creatorcontrib>Altamirano-Jimenez, Armando</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of tropical medicine and hygiene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodriguez, Mario H</au><au>Betanzos-Reyes, Angel F</au><au>Hernandez-Avila, Juan E</au><au>Mendez-Galvan, Jorge F</au><au>Danis-Lozano, Rogelio</au><au>Altamirano-Jimenez, Armando</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Participation of Secondary Clinical Episodes in the Epidemiology of Vivax Malaria during Pre- and Post-Implementation of Focal Control in the State of Oaxaca, Mexico</atitle><jtitle>The American journal of tropical medicine and hygiene</jtitle><addtitle>Am J Trop Med Hyg</addtitle><date>2009-06-01</date><risdate>2009</risdate><volume>80</volume><issue>6</issue><spage>889</spage><epage>895</epage><pages>889-895</pages><issn>0002-9637</issn><eissn>1476-1645</eissn><coden>AJTHAB</coden><abstract>The participation of vivax malaria secondary clinical was researched in a retrospective cohort of 33,414 confirmed cases occurring between 1994 and 2005 in the state of Oaxaca, Mexico. Secondary episodes occurred in 23.4% of all primary cases. An increase in secondary episodes was associated with primary cases occurring during the dry seasons (risk ratio [RR] = 1.68, 95% CI: 1.45-1.96). The incidence of secondary episodes peaked at an older age, occurred similarly in men and women mostly during low mosquito abundance, and had a uniform distribution among localities. A reduction in secondary episodes was associated with the administration of an increased dose and early administration of primaquine (RR = 0.32, 95% CI: 0.26-0.38). However, limitations to distinguish relapses from re-infections impede assessment of the new treatment effect on relapses and its contribution to malaria control in the area. These findings highlight the need for new therapeutic schemes to radical cure of P. vivax infections and operational research aimed at parasite pool elimination.</abstract><cop>Deerfield, IL</cop><pub>ASTMH</pub><pmid>19478244</pmid><doi>10.4269/ajtmh.2009.80.889</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9637
ispartof The American journal of tropical medicine and hygiene, 2009-06, Vol.80 (6), p.889-895
issn 0002-9637
1476-1645
language eng
recordid cdi_proquest_miscellaneous_67283766
source MEDLINE; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Antimalarials - administration & dosage
Antimalarials - therapeutic use
Biological and medical sciences
Child
Child, Preschool
Chloroquine - administration & dosage
Chloroquine - therapeutic use
Cohort Studies
Drug Therapy, Combination
Female
Human protozoal diseases
Humans
Incidence
Infant
Infectious diseases
Malaria
Malaria, Vivax - epidemiology
Malaria, Vivax - prevention & control
Male
Medical sciences
Mexico - epidemiology
Middle Aged
Mosquito Control - methods
Parasitic diseases
Primaquine - administration & dosage
Primaquine - therapeutic use
Protozoal diseases
Retrospective Studies
Seasons
Young Adult
title The Participation of Secondary Clinical Episodes in the Epidemiology of Vivax Malaria during Pre- and Post-Implementation of Focal Control in the State of Oaxaca, Mexico
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T02%3A16%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Participation%20of%20Secondary%20Clinical%20Episodes%20in%20the%20Epidemiology%20of%20Vivax%20Malaria%20during%20Pre-%20and%20Post-Implementation%20of%20Focal%20Control%20in%20the%20State%20of%20Oaxaca,%20Mexico&rft.jtitle=The%20American%20journal%20of%20tropical%20medicine%20and%20hygiene&rft.au=Rodriguez,%20Mario%20H&rft.date=2009-06-01&rft.volume=80&rft.issue=6&rft.spage=889&rft.epage=895&rft.pages=889-895&rft.issn=0002-9637&rft.eissn=1476-1645&rft.coden=AJTHAB&rft_id=info:doi/10.4269/ajtmh.2009.80.889&rft_dat=%3Cproquest_cross%3E20802804%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20802804&rft_id=info:pmid/19478244&rfr_iscdi=true